

Immunotherapy Part II
Feb 9, 2024
In this podcast, special guest Matt McKenzie, PharmD, BCCCP, discusses various aspects of immunotherapy, including CAR-T cell therapy, cytokine release syndrome (CRS), immune effector cell-associated neurotoxicity syndrome (ICANS), and immune checkpoint inhibitors. The episode also highlights the complexity of immunotherapy guidelines, challenges in symptom identification, grading scales for CRS and ICANS, adverse effects of HLH in immunotherapy, and the evolving nature of the topic.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7 8
Introduction
00:00 • 3min
Introduction to Immunotherapy
03:08 • 15min
Complexity of Immunotherapy Guidelines
18:11 • 22min
Challenges in Symptom Identification and Long-Term Effects of CAR-T Cell Therapies
39:58 • 1min
Grading Scales for CRS and ICANS in CAR T Cell Therapy
41:20 • 8min
Adverse Effects and Treatment of HLH in Immunotherapy
48:58 • 2min
Understanding Immune Checkpoint Inhibitors
50:45 • 22min
Evolving Nature of Topic and 'Mattress Mac' Anecdote
01:13:09 • 5min